Alzheimer's Disease Clinical Trials in Kansas

7 recruiting studies across 3 cities

All Trials in Kansas

Phase
Trial Phase Location
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)Phase 2Fairway
A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)Phase 1/2Fairway
Testing the Effects of a Text Message Caregiver Support Intervention for LatinosN/AFairway
Adapting RDAD for DSN/AKansas City
Brain Outcomes With Lifestyle Change in Down SyndromeN/AKansas City
Trial-Ready Cohort-Down Syndrome (TRC-DS)—Kansas City
Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's DiseasePhase 2Wichita

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.